HEADER HYDROLASE/HYDROLASE INHIBITOR 29-MAR-15 4Z2B
TITLE THE STRUCTURE OF HUMAN PDE12 RESIDUES 161-609 IN COMPLEX WITH
TITLE 2 GSK3036342A
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 2',5'-PHOSPHODIESTERASE 12;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: UNP RESIDUES 155-609;
COMPND 5 SYNONYM: 2-PDE,MITOCHONDRIAL DEADENYLASE;
COMPND 6 EC: 3.1.4.-,3.1.13.4;
COMPND 7 ENGINEERED: YES;
COMPND 8 OTHER_DETAILS: TEV CLONING TAG ON N-TERMINUS
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PDE12;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21;
SOURCE 9 EXPRESSION_SYSTEM_VARIANT: DE3
KEYWDS PDE12 2'-5'A EEP NUCLEASE INHIBITOR COMPLEX, HYDROLASE-HYDROLASE
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR R.T.NOLTE,B.WISELY,L.WANG,E.R.WOOD
REVDAT 4 27-SEP-23 4Z2B 1 JRNL REMARK
REVDAT 3 19-AUG-15 4Z2B 1 JRNL
REVDAT 2 24-JUN-15 4Z2B 1 JRNL
REVDAT 1 17-JUN-15 4Z2B 0
JRNL AUTH E.R.WOOD,R.BLEDSOE,J.CHAI,P.DAKA,H.DENG,Y.DING,
JRNL AUTH 2 S.HARRIS-GURLEY,L.H.KRYN,E.NARTEY,J.NICHOLS,R.T.NOLTE,
JRNL AUTH 3 N.PRABHU,C.RISE,T.SHEAHAN,J.B.SHOTWELL,D.SMITH,V.TAI,
JRNL AUTH 4 J.D.TAYLOR,G.TOMBERLIN,L.WANG,B.WISELY,S.YOU,B.XIA,H.DICKSON
JRNL TITL THE ROLE OF PHOSPHODIESTERASE 12 (PDE12) AS A NEGATIVE
JRNL TITL 2 REGULATOR OF THE INNATE IMMUNE RESPONSE AND THE DISCOVERY OF
JRNL TITL 3 ANTIVIRAL INHIBITORS.
JRNL REF J.BIOL.CHEM. V. 290 19681 2015
JRNL REFN ESSN 1083-351X
JRNL PMID 26055709
JRNL DOI 10.1074/JBC.M115.653113
REMARK 2
REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.6
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.30
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 90.0
REMARK 3 NUMBER OF REFLECTIONS : 39837
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.183
REMARK 3 R VALUE (WORKING SET) : 0.182
REMARK 3 FREE R VALUE : 0.218
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.150
REMARK 3 FREE R VALUE TEST SET COUNT : 1255
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.85
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.99
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1700
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2234
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1652
REMARK 3 BIN R VALUE (WORKING SET) : 0.2227
REMARK 3 BIN FREE R VALUE : 0.2505
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.82
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 48
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3532
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 59
REMARK 3 SOLVENT ATOMS : 462
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 20.62
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.79
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.41480
REMARK 3 B22 (A**2) : 0.12250
REMARK 3 B33 (A**2) : 0.29230
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.201
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.153
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.135
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.141
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.130
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 3743 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 5104 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1673 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 548 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 3743 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 473 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 4786 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 0.98
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.99
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.52
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4Z2B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-APR-15.
REMARK 100 THE DEPOSITION ID IS D_1000208496.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 12-SEP-12
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : MULTILAYER OPTICS
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40745
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9
REMARK 200 DATA REDUNDANCY : 4.800
REMARK 200 R MERGE (I) : 0.05400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83
REMARK 200 COMPLETENESS FOR SHELL (%) : 66.1
REMARK 200 DATA REDUNDANCY IN SHELL : 2.10
REMARK 200 R MERGE FOR SHELL (I) : 0.26600
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER 2.5.1
REMARK 200 STARTING MODEL: 3NG0
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 47.07
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.5 15% PEG20000 25%
REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.15450
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.44000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.26600
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.44000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.15450
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.26600
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 TYR A 155
REMARK 465 LYS A 156
REMARK 465 VAL A 157
REMARK 465 GLU A 158
REMARK 465 ARG A 159
REMARK 465 ASN A 160
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 ASP A 189 CG OD1 OD2
REMARK 470 LYS A 202 CE NZ
REMARK 470 GLU A 291 CG CD OE1 OE2
REMARK 470 GLU A 573 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 303 104.92 64.05
REMARK 500 SER A 360 -58.25 -121.17
REMARK 500 LYS A 377 -81.99 -101.51
REMARK 500 LYS A 377 -81.39 -101.94
REMARK 500 GLN A 378 -65.83 -135.54
REMARK 500 LEU A 394 -61.21 -91.19
REMARK 500 HIS A 397 50.98 -141.45
REMARK 500 CYS A 530 55.07 -151.64
REMARK 500 GLN A 588 -61.10 72.13
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A1261 DISTANCE = 6.23 ANGSTROMS
REMARK 525 HOH A1262 DISTANCE = 8.41 ANGSTROMS
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG A 706 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP A 598 OD2
REMARK 620 2 4LC A 705 O18 109.9
REMARK 620 3 HOH A 828 O 80.5 161.6
REMARK 620 4 HOH A 847 O 125.6 80.2 81.4
REMARK 620 5 HOH A1038 O 74.7 103.9 93.4 157.2
REMARK 620 N 1 2 3 4
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 701
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 702
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 703
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue TRS A 704
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 4LC A 705
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 706
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4Z0V RELATED DB: PDB
REMARK 900 RELATED UNLIGANDED PROTEIN STRUCTURE
DBREF 4Z2B A 155 609 UNP Q6L8Q7 PDE12_HUMAN 155 609
SEQRES 1 A 455 TYR LYS VAL GLU ARG ASN PRO PRO ALA PHE THR GLU LEU
SEQRES 2 A 455 GLN LEU PRO ARG TYR ILE MET ALA GLY PHE PRO VAL CYS
SEQRES 3 A 455 PRO LYS LEU SER LEU GLU PHE GLY ASP PRO ALA SER SER
SEQRES 4 A 455 LEU PHE ARG TRP TYR LYS GLU ALA LYS PRO GLY ALA ALA
SEQRES 5 A 455 GLU PRO GLU VAL GLY VAL PRO SER SER LEU SER PRO SER
SEQRES 6 A 455 SER PRO SER SER SER TRP THR GLU THR ASP VAL GLU GLU
SEQRES 7 A 455 ARG VAL TYR THR PRO SER ASN ALA ASP ILE GLY LEU ARG
SEQRES 8 A 455 LEU LYS LEU HIS CYS THR PRO GLY ASP GLY GLN ARG PHE
SEQRES 9 A 455 GLY HIS SER ARG GLU LEU GLU SER VAL CYS VAL VAL GLU
SEQRES 10 A 455 ALA GLY PRO GLY THR CYS THR PHE ASP HIS ARG HIS LEU
SEQRES 11 A 455 TYR THR LYS LYS VAL THR GLU ASP ALA LEU ILE ARG THR
SEQRES 12 A 455 VAL SER TYR ASN ILE LEU ALA ASP THR TYR ALA GLN THR
SEQRES 13 A 455 GLU PHE SER ARG THR VAL LEU TYR PRO TYR CYS ALA PRO
SEQRES 14 A 455 TYR ALA LEU GLU LEU ASP TYR ARG GLN ASN LEU ILE GLN
SEQRES 15 A 455 LYS GLU LEU THR GLY TYR ASN ALA ASP VAL ILE CYS LEU
SEQRES 16 A 455 GLN GLU VAL ASP ARG ALA VAL PHE SER ASP SER LEU VAL
SEQRES 17 A 455 PRO ALA LEU GLU ALA PHE GLY LEU GLU GLY VAL PHE ARG
SEQRES 18 A 455 ILE LYS GLN HIS GLU GLY LEU ALA THR PHE TYR ARG LYS
SEQRES 19 A 455 SER LYS PHE SER LEU LEU SER GLN HIS ASP ILE SER PHE
SEQRES 20 A 455 TYR GLU ALA LEU GLU SER ASP PRO LEU HIS LYS GLU LEU
SEQRES 21 A 455 LEU GLU LYS LEU VAL LEU TYR PRO SER ALA GLN GLU LYS
SEQRES 22 A 455 VAL LEU GLN ARG SER SER VAL LEU GLN VAL SER VAL LEU
SEQRES 23 A 455 GLN SER THR LYS ASP SER SER LYS ARG ILE CYS VAL ALA
SEQRES 24 A 455 ASN THR HIS LEU TYR TRP HIS PRO LYS GLY GLY TYR ILE
SEQRES 25 A 455 ARG LEU ILE GLN MET ALA VAL ALA LEU ALA HIS ILE ARG
SEQRES 26 A 455 HIS VAL SER CYS ASP LEU TYR PRO GLY ILE PRO VAL ILE
SEQRES 27 A 455 PHE CYS GLY ASP PHE ASN SER THR PRO SER THR GLY MET
SEQRES 28 A 455 TYR HIS PHE VAL ILE ASN GLY SER ILE PRO GLU ASP HIS
SEQRES 29 A 455 GLU ASP TRP ALA SER ASN GLY GLU GLU GLU ARG CYS ASN
SEQRES 30 A 455 MET SER LEU THR HIS PHE PHE LYS LEU LYS SER ALA CYS
SEQRES 31 A 455 GLY GLU PRO ALA TYR THR ASN TYR VAL GLY GLY PHE HIS
SEQRES 32 A 455 GLY CYS LEU ASP TYR ILE PHE ILE ASP LEU ASN ALA LEU
SEQRES 33 A 455 GLU VAL GLU GLN VAL ILE PRO LEU PRO SER HIS GLU GLU
SEQRES 34 A 455 VAL THR THR HIS GLN ALA LEU PRO SER VAL SER HIS PRO
SEQRES 35 A 455 SER ASP HIS ILE ALA LEU VAL CYS ASP LEU LYS TRP LYS
HET SO4 A 701 5
HET EDO A 702 4
HET EDO A 703 4
HET TRS A 704 8
HET 4LC A 705 37
HET MG A 706 1
HETNAM SO4 SULFATE ION
HETNAM EDO 1,2-ETHANEDIOL
HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL
HETNAM 4LC 3-(6-{[(2S,3S)-3-(HYDROXYMETHYL)-2-PHENYLMORPHOLIN-4-
HETNAM 2 4LC YL]CARBONYL}-1-METHYL-1H-BENZIMIDAZOL-2-YL)-1H-INDOLE-
HETNAM 3 4LC 6-CARBONITRILE
HETNAM MG MAGNESIUM ION
HETSYN EDO ETHYLENE GLYCOL
HETSYN TRS TRIS BUFFER
FORMUL 2 SO4 O4 S 2-
FORMUL 3 EDO 2(C2 H6 O2)
FORMUL 5 TRS C4 H12 N O3 1+
FORMUL 6 4LC C29 H25 N5 O3
FORMUL 7 MG MG 2+
FORMUL 8 HOH *462(H2 O)
HELIX 1 AA1 ASP A 189 SER A 193 5 5
HELIX 2 AA2 PRO A 213 SER A 217 5 5
HELIX 3 AA3 SER A 238 ILE A 242 5 5
HELIX 4 AA4 THR A 278 LEU A 284 1 7
HELIX 5 AA5 ALA A 304 GLN A 309 1 6
HELIX 6 AA6 THR A 310 VAL A 316 1 7
HELIX 7 AA7 ALA A 322 LEU A 326 5 5
HELIX 8 AA8 GLU A 327 TYR A 342 1 16
HELIX 9 AA9 ASP A 353 SER A 360 1 8
HELIX 10 AB1 SER A 360 PHE A 368 1 9
HELIX 11 AB2 PHE A 401 ASP A 408 1 8
HELIX 12 AB3 HIS A 411 LEU A 420 1 10
HELIX 13 AB4 TYR A 421 GLN A 430 1 10
HELIX 14 AB5 GLY A 463 ASP A 484 1 22
HELIX 15 AB6 THR A 503 GLY A 512 1 10
HELIX 16 AB7 HIS A 518 SER A 523 5 6
HELIX 17 AB8 SER A 580 THR A 585 1 6
SHEET 1 AA1 2 ALA A 163 GLN A 168 0
SHEET 2 AA1 2 LYS A 182 GLU A 186 -1 O GLU A 186 N ALA A 163
SHEET 1 AA2 2 ILE A 173 MET A 174 0
SHEET 2 AA2 2 VAL A 270 GLU A 271 1 O GLU A 271 N ILE A 173
SHEET 1 AA3 4 TRP A 225 GLU A 227 0
SHEET 2 AA3 4 LEU A 194 GLU A 200 -1 N LYS A 199 O THR A 226
SHEET 3 AA3 4 LEU A 246 THR A 251 -1 O LYS A 247 N TYR A 198
SHEET 4 AA3 4 ARG A 262 GLU A 265 -1 O ARG A 262 N CYS A 250
SHEET 1 AA4 6 LEU A 370 ILE A 376 0
SHEET 2 AA4 6 GLY A 381 ARG A 387 -1 O LEU A 382 N ARG A 375
SHEET 3 AA4 6 VAL A 346 VAL A 352 -1 N LEU A 349 O ALA A 383
SHEET 4 AA4 6 LEU A 294 ASN A 301 1 N VAL A 298 O CYS A 348
SHEET 5 AA4 6 LEU A 602 TRP A 608 -1 O CYS A 604 N THR A 297
SHEET 6 AA4 6 LEU A 570 VAL A 575 -1 N GLU A 573 O ASP A 605
SHEET 1 AA5 3 PHE A 391 GLN A 396 0
SHEET 2 AA5 3 VAL A 434 SER A 442 -1 O VAL A 439 N SER A 395
SHEET 3 AA5 3 ILE A 399 SER A 400 -1 N ILE A 399 O LEU A 435
SHEET 1 AA6 6 PHE A 391 GLN A 396 0
SHEET 2 AA6 6 VAL A 434 SER A 442 -1 O VAL A 439 N SER A 395
SHEET 3 AA6 6 ARG A 449 HIS A 456 -1 O VAL A 452 N SER A 438
SHEET 4 AA6 6 VAL A 491 ASP A 496 1 O ILE A 492 N ALA A 453
SHEET 5 AA6 6 ASP A 561 ASP A 566 -1 O PHE A 564 N PHE A 493
SHEET 6 AA6 6 LEU A 540 SER A 542 -1 N LYS A 541 O ILE A 565
SHEET 1 AA7 2 SER A 513 ILE A 514 0
SHEET 2 AA7 2 LEU A 534 THR A 535 -1 O LEU A 534 N ILE A 514
SHEET 1 AA8 2 ASN A 551 TYR A 552 0
SHEET 2 AA8 2 HIS A 557 GLY A 558 -1 O GLY A 558 N ASN A 551
LINK OD2 ASP A 598 MG MG A 706 1555 1555 2.80
LINK O18 4LC A 705 MG MG A 706 1555 1555 2.68
LINK MG MG A 706 O HOH A 828 1555 1555 2.21
LINK MG MG A 706 O HOH A 847 1555 1555 2.19
LINK MG MG A 706 O HOH A1038 1555 1555 2.36
CISPEP 1 LEU A 590 PRO A 591 0 -7.76
SITE 1 AC1 9 GLU A 207 LYS A 377 ARG A 431 SER A 432
SITE 2 AC1 9 TYR A 458 EDO A 702 HOH A 822 HOH A 843
SITE 3 AC1 9 HOH A 893
SITE 1 AC2 7 LYS A 377 SER A 433 HIS A 456 LEU A 457
SITE 2 AC2 7 TYR A 458 TRP A 459 SO4 A 701
SITE 1 AC3 6 PHE A 177 PRO A 274 GLY A 275 CYS A 277
SITE 2 AC3 6 ASP A 280 LYS A 337
SITE 1 AC4 9 HIS A 281 LYS A 412 GLU A 416 SER A 580
SITE 2 AC4 9 GLU A 583 HOH A 818 HOH A 857 HOH A 936
SITE 3 AC4 9 HOH A1037
SITE 1 AC5 19 PRO A 208 GLU A 209 TYR A 307 THR A 310
SITE 2 AC5 19 SER A 313 GLU A 351 TRP A 459 PRO A 461
SITE 3 AC5 19 ASN A 498 SER A 499 THR A 500 THR A 503
SITE 4 AC5 19 PHE A 556 MG A 706 HOH A 842 HOH A 844
SITE 5 AC5 19 HOH A 920 HOH A 973 HOH A1098
SITE 1 AC6 6 GLU A 351 ASP A 598 4LC A 705 HOH A 828
SITE 2 AC6 6 HOH A 847 HOH A1038
CRYST1 56.309 66.532 124.880 90.00 90.00 90.00 P 21 21 21 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.017759 0.000000 0.000000 0.00000
SCALE2 0.000000 0.015030 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008008 0.00000